<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title-group>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2025.1622066</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Local policy governance arrangements and COVID-19-related mortality in municipalities in Japan: a cross-sectional ecological study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Nakamoto</surname>
<given-names>Yuki</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3045788"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>Hideki</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<uri xlink:href="https://loop.frontiersin.org/people/336836"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Department of Health and Social Behavior, School of Public Health, The University of Tokyo</institution>, <city>Tokyo</city>, <country country="jp">Japan</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Yuki Nakamoto, <email xlink:href="mailto:nakamoto@m.u-tokyo.ac.jp">nakamoto@m.u-tokyo.ac.jp</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-30">
<day>30</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1622066</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>03</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2026 Nakamoto and Hashimoto.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Nakamoto and Hashimoto</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-30">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>COVID-19-related mortality varied substantially within and across countries, which may not be fully explained by demographic and clinical differences. Some studies suggest that local governors&#x2019; ideology has a substantial effect on mortality because of their political stances for and against the stringency of public health interventions. However, recent research indicates that stringency is not consistently related to lower mortality. This study investigated whether regional differences in COVID-19 mortality are attributable to differences in local governance arrangements for collaborative policy responses to pandemic situations in Japan, where local infection control was managed via a decentralized system.</p>
</sec>
<sec>
<title>Methods</title>
<p>From December 2020 to November 2021, we conducted a city-level, cross-sectional, ecological study of 20 cities designated by the government ordinance of Japan. COVID-19-related mortality rates were obtained per 3-month period to account for viral variant change. The local deliberative decision to suspend the national health insurance policy that temporarily revokes the benefit eligibility of households because of unpaid premiums was considered an indicator of flexible and collaborative governance, as the decision required unanimous consensus from diverse stakeholders within and across local government institutes. Negative binomial regression was used adjusting for covariates, including population density and emergency care accessibility.</p>
</sec>
<sec>
<title>Results</title>
<p>During the study, 5,383 COVID-19-related deaths were reported. Of the 20 cities, five had implemented the suspension decision before or during the pandemic. Cities with the suspension policy showed an adjusted mortality relative risk of 0.75 (95% confidence interval: 0.60 to 0.94) compared with cities that retained the temporary revocation policy. Conclusions: The results suggest that local governments with flexible collaborative policymaking were more successful in mitigating the COVID-19 mortality impact in Japan. The findings highlight the potentially important effect of governance arrangements on population health disparities.</p>
</sec>
</abstract>
<kwd-group>
<kwd>collaborative governance</kwd>
<kwd>COVID-19</kwd>
<kwd>governance arrangements</kwd>
<kwd>Japan</kwd>
<kwd>social determinants of health</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This research was partially funded by Grant-in-Aid for Challenging Research (Pioneering), grant number JP22K18404. It was completed as part of a PhD program of study by YN, the fees for which were provided by the JST SPRING (grant number: JPMJSP2108).</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="61"/>
<page-count count="9"/>
<word-count count="6926"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Public Health Policy</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>The concept of social determinants of health is used to explain population health differences across countries, regions, and social strata (<xref ref-type="bibr" rid="ref1">1</xref>). Previous studies have focused on the social determinants of local government and related public policy administration to explain population-level health outcomes (<xref ref-type="bibr" rid="ref2 ref3 ref4">2&#x2013;4</xref>). The important role of local governments in influencing population health has attracted renewed interest in the USA since the COVID-19 pandemic (<xref ref-type="bibr" rid="ref5">5</xref>). Several studies indicate that the public policy response in terms of stringent social policies such as mask wearing, mandated vaccination, and lockdown was politicized owing to the political affiliations and ideologies of US governors, resulting in regional variation in COVID-19-related case incidence and mortality (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref6">6</xref>, <xref ref-type="bibr" rid="ref7">7</xref>). However, recent cross-country studies indicate that policy stringency was not consistently related to lower case incidence and mortality; rather, owing to a pattern of reverse causality, higher death rates may have forced governments to adopt more stringent policies (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref9">9</xref>). One political cross-country analysis also failed to detect an association between policy stringency and lower population mortality, and found that the quality of governance (in addition to population risk factors) was strongly associated with lower mortality (<xref ref-type="bibr" rid="ref10">10</xref>). Therefore, the aspects of local government that affect population health disparity remain to be determined.</p>
<p>Japan had relatively low case fatality and population mortality during the COVID-19 pandemic (<xref ref-type="bibr" rid="ref11">11</xref>), although there was a substantial disparity in mortality across regions (<xref ref-type="bibr" rid="ref12">12</xref>). This disparity may not be fully explained by demographic, socioeconomic, or clinical risk factors, or by medical service accessibility (<xref ref-type="bibr" rid="ref13">13</xref>). The prefecture with the highest COVID-19-related mortality was Osaka. Its capital, Osaka City, is the second-largest city in Japan and contains a large number of accessible major hospitals. Okinawa Prefecture had relatively moderate COVID-19-related mortality. Okinawa is one of the economically poorest prefectures, and has fewer accessible medical resources owing to its remote island location (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref15">15</xref>). Japan&#x2019;s Infection Control Act mandates that local governments are responsible for policy responses to ensure infection control (<xref ref-type="bibr" rid="ref16">16</xref>). The above-mentioned research suggests that local government responses had an important effect on population outcomes related to the COVID-19 pandemic. It has been argued that coordinated networking within/between levels of government (central, prefecture, and municipality) is essential for effective and timely infection control under Japan&#x2019;s decentralized governance structure (<xref ref-type="bibr" rid="ref17">17</xref>).</p>
<p>Previous studies have highlighted the importance of collaboration among multiple stakeholders and local governments in implementing infection control and non-pharmaceutical interventions during the COVID-19 pandemic (<xref ref-type="bibr" rid="ref18">18</xref>). However, many such studies are case studies and lack empirical analysis of comparisons across municipalities. In this study, we hypothesized that the governance arrangements of local governments were associated with COVID-19-related mortality rates. Specifically, we examined whether the use of government administrative frameworks incorporating flexible policymaking by integrating the perspectives of various sectors and stakeholders was associated with lower COVID-19-related mortality rates.</p>
</sec>
<sec sec-type="methods" id="sec2">
<label>2</label>
<title>Methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Study design</title>
<p>We used a cross-sectional, city-level, ecological design to test the hypothesis. We used 20 municipality cities designated by the government ordinance of Japan under the Local Government Act as a unit of analysis for two reasons. First, all these cities have populations above 500,000, and an independent local public health center on the frontline of infection control under the governance of the local mayor (<xref ref-type="bibr" rid="ref19">19</xref>, <xref ref-type="bibr" rid="ref20">20</xref>). These cities also have urban economic and health infrastructures. Second, the numbers of COVID-19 cases and deaths per month in the designated cities are publicly available. These cities also manage standard citizen services and have greater autonomy in social welfare, public health, urban planning, management of national roads, and compulsory education (<xref ref-type="bibr" rid="ref19">19</xref>).</p>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Identification of municipal governments with administrative frameworks for flexible policymaking</title>
<p>Worldwide Governance Indicators are well-known comprehensive measures of country-level governance characteristics (<xref ref-type="bibr" rid="ref21">21</xref>), although they may not be easily applicable to local governments, which have different powers and responsibilities than central governments. For example, &#x201C;the kind of voice and accountability&#x201D; refers to levels of democracy, such as freedom of political participation, expression, and elections, which may not be appropriate to apply at the local government level (<xref ref-type="bibr" rid="ref22">22</xref>).</p>
<p>Because of the lack of standardized and applicable measures for our purpose, we chose a local policy of temporary benefit revocation for unpaid premiums under the national health insurance system to measure the extent to which local governments used administrative frameworks to manage policy consensus from various sectors and stakeholders. The rationale for this is as follows.</p>
<p>Japan&#x2019;s public national health insurance system provides universal cover for community residents and is implemented by local government insurers under the National Health Insurance Act (<xref ref-type="bibr" rid="ref23">23</xref>). The system mandates premium contributions according to household size and income level, and offers full medical, dental, and pharmaceutical coverage with a standardized copayment rate. However, Article 9 of the Act stipulates that individuals who default on their premium payments for a year or longer will be temporarily ineligible for coverage when utilizing healthcare services, and will be subject to full out-of-pocket medical visit expenses until the premium payments are no longer in arrears (<xref ref-type="bibr" rid="ref24">24</xref>). During the period of ineligibility, the local municipality&#x2019;s government insurers are mandated to issue a &#x201C;certification of beneficiary status,&#x201D; which guarantees that out-of-pocket payments will be reimbursed after confirmation of premium payments.</p>
<p>Although the issuance of status certification is generally mandated, an exemption may be applied if the local government makes a policy decision to suspend the temporary revocation of benefits. Such decisions are approved following unanimous consensus across the mayor&#x2019;s office, city council, and other related parties, and are made for various reasons, including welfare (e.g., to ensure equal benefits for poorer households) or for management (e.g., avoiding the costs involved in temporarily revoking benefits).</p>
<p>Regardless of the reason for these decisions, implementing and maintaining the suspension policy necessitates complex policy processes that require coordination and unanimous consensus between the mayor, the insurance bureau, related sectors in the municipality office, the municipal council, and other internal and external actors whose interests and political values vary widely. Following the National Health Insurance Act, Local Councils for the Administration of National Health Insurance (statutory advisory councils), which comprise representative insured persons and medical providers, are required to submit an advisory opinion to the mayor on whether the suspension policy is relevant and feasible in ensuring equality of both benefits and contributions (<xref ref-type="bibr" rid="ref24">24</xref>). The city councils have the power to determine the legitimacy of the suspension policy in relation to the city budget (<xref ref-type="bibr" rid="ref25">25</xref>), and the prefecture functions as a supervisory agency for municipality insurer offices for jurisdiction and bureaucratic feasibility (<xref ref-type="bibr" rid="ref24">24</xref>). These complex processes mean that local governments that intend to adopt the suspension policy must have the administrative capacity to align divergent perspectives across sectors and stakeholders. The required governance framework corresponds to the &#x201C;collaborative governance&#x201D; model, which involves collaboration across diverse stakeholders in multiple sectors to address public service issues through collective efforts, promoting flexible actions based on trust and legitimacy (<xref ref-type="bibr" rid="ref26">26</xref>).</p>
<p>The suspension policy is implemented through processes involving multiple stakeholders and iterative activities across five interrelated functions (<xref ref-type="fig" rid="fig1">Figure 1</xref>): (i) groundwork laid by the National Health Insurance division; (ii) coordination between the legal, finance, and revenue-collection departments; (iii) deliberation by the statutory advisory council; (iv) decision-making by the mayor&#x2019;s office; and (v) authorization and budgeting by the city council. These functions interact and repeat rather than unfolding as a fixed sequence of discrete tasks, and they require cooperation across both administrative and political entities.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Collaboration dynamics as the necessary condition for the suspension policy. Principled engagement involves discovery, definition, deliberation, and determination. Shared motivation refers to mutual trust, mutual understanding, internal legitimacy, and shared commitment. Capacity for joint action comprises procedural and institutional arrangements, leadership, knowledge, and resources. Curved arrows denote iterative interactions; the rightward arrow denotes translation into the suspension policy. Labels (i&#x2013;v) indicate the primary association between approval/coordination domains and each element; associations are non-exclusive, and no unique order is implied.</p>
</caption>
<graphic xlink:href="fpubh-13-1622066-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">A flowchart titled "Collaboration Dynamics" includes three interconnected gears labeled "Principled Engagement," "Shared Motivation," and "Capacity for Joint Action." Principled Engagement involves cross-department deliberation and statutory advisory council discovery. Shared Motivation involves the mayor's office legitimacy and city council's mutual trust. Capacity for Joint Action involves the National Health Insurance division and city council resources. The output is "the Suspension Policy." Arrows indicate the flow among these components.</alt-text>
</graphic>
</fig>
<p>In alignment with Emerson et al. (<xref ref-type="bibr" rid="ref26">26</xref>) collaboration dynamics framework, this process unfolds through iterative interactions between three domains: principled engagement, which structures discovery, definition, deliberation, and determination; shared motivation, which involves building mutual trust, mutual understanding, internal legitimacy, and shared commitment; and capacity for joint action, characterized by concrete procedural and institutional arrangements, leadership, knowledge, and resources. We therefore consider the adoption of the suspension policy as a collaborative governance outcome that arises from iterative, mutually reinforcing interactions between principled engagement, shared motivation, and capacity for joint action throughout this governance process. <xref ref-type="fig" rid="fig1">Figure 1</xref> illustrates how these functions relate to the three domains. Thus, we interpret this publicly visible decision as a stringent test of municipal collaborative governance capacity.</p>
<p>The implementation of such complex policymaking processes, particularly the suspension policy, is unlikely to simply reflect an ideological motivation to attract voting interests from liberal parties. This is because only 0.2% of households in Japan are subject to temporary benefit revocation (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref28">28</xref>), and there is strong support for benefit revocation as a way of ensuring contribution fairness. Thus, contrary to the US discussion about the politicization of pandemic control, the suspension policy cannot be fully explained by the dominant ideology of local government.</p>
<p>Additionally, the suspension policy per se did not theoretically affect accessibility to medical treatment for COVID-19, as the Central Government Ministry announced conditional exceptions to the revocation policy for COVID-19-related consultations as of November 2020 (<xref ref-type="bibr" rid="ref29">29</xref>), before the sampling period of the current study began. The aim of these exceptions was to facilitate equitable access to required medical services for people in poverty. Although access to medical care for non-COVID-19 conditions was discouraged owing to the revocation of benefit eligibility (<xref ref-type="bibr" rid="ref30">30</xref>), this would not have affected the COVID-19-related mortality rate. Thus, any association between the policy of suspending benefit eligibility revocation and reductions in COVID-19-related mortality in a municipality should be related to municipal-level management of pandemic-related policy decisions (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref31">31</xref>) rather than subsequent improvement of medical care access for people in poverty. We argue that the suspension policy may be an indicator of the governance style of local governments that used coordinated and collaborative policy management across health and non-health sectors to effectively respond to the ongoing challenges of the pandemic.</p>
<p>We treat policy outputs as observable manifestations of collaborative governance. Among potential outputs, suspension was selected as the indicator because it is formally decided and documented, requires non-sequential alignment across the domains described above, and is conceptually anchored in the three collaboration dynamic domains operating iteratively (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This theory-guided operationalization provides content validity for municipal-level inference.</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>Data source</title>
<p>The monthly cumulative number of confirmed COVID-19-related deaths was the study outcome (<xref ref-type="bibr" rid="ref32">32</xref>). Death data from December 2020 to November 2021 were compiled quarterly to reflect different COVID-19 variant outbreaks. Before December 2020, the original strain dominated the first period, and the Alpha variant dominated the second period in Japan. During the study period, the Delta variant became more prevalent; this was followed by the Omicron variant outbreak, during which the death count rapidly increased (<xref ref-type="bibr" rid="ref16">16</xref>).</p>
<p>To measure city-level governance arrangements, we collected data on the suspension or continuation of temporary benefit revocation in each city by reviewing the minutes of meetings of its city council and the Local Council for the Administration of National Health Insurance. In July 2023, we confirmed that information by phone calls to each city. Cities with a policy of suspending temporary benefit revocation under the national health insurance system were assumed to have governments with administrative frameworks for flexible and collaborative policymaking (as argued above). Because significant changes in governance typically require more than 5&#x202F;years (<xref ref-type="bibr" rid="ref33">33</xref>), we classified cases as having a suspension policy from the beginning of the observation period, even if the policy was instituted during that time.</p>
<p>The following city-level covariates were measured: (1) proportion of the population aged 75&#x202F;years or over (<xref ref-type="bibr" rid="ref27">27</xref>), (2) number of acute care hospital beds per population (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref34">34</xref>), (3) proportion of nursing home residents (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref35">35</xref>), and (4) population density (in thousands of people per km<sup>2</sup>) (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref36">36</xref>), as factors that may affect death rates, following a previous study (<xref ref-type="bibr" rid="ref13">13</xref>). The specific covariate formulas are shown in <xref ref-type="table" rid="tab1">Table 1</xref>.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Data sources and calculation methods for covariates.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Covariate</th>
<th align="left" valign="top">Calculation method</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">(1) Proportion of population aged &#x2265;75&#x202F;years</td>
<td align="left" valign="middle">Population aged &#x2265;75&#x202F;years (27)/City population (27)</td>
</tr>
<tr>
<td align="left" valign="middle">(2) Number of acute care hospital beds per population</td>
<td align="left" valign="middle">Number of beds in emergency hospitals (34)/City population (27)</td>
</tr>
<tr>
<td align="left" valign="middle">(3) Proportion of nursing home residents</td>
<td align="left" valign="middle">(Number of persons using nursing homes over 12&#x202F;months (35)/12&#x202F;&#x2212;&#x202F;Residents in facilities outside the city (35))/City population (27)</td>
</tr>
<tr>
<td align="left" valign="middle">(4) Population density</td>
<td align="left" valign="middle">City population (27)/1,000/Square kilometers of habitable land area (36)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>Statistical analysis</title>
<p>We used negative binomial regression to address over-dispersion (<xref ref-type="bibr" rid="ref37">37</xref>). This method was applied to assess the association between COVID-19-related deaths and the suspension of temporary benefit revocation, adjusting for covariates and periods across the 20 cities. We designated the first 3&#x202F;months as the reference period. The logarithmic value of the number of deaths at the city level was set as the outcome variable. To account for differences in city population size, we included the logarithmic value of the city population as an offset term. Additionally, we clustered standard errors at the city level to account for within-city correlations across periods. All analyses were conducted using Stata/IC version 14.2 (Stata Corporation, College Station, Texas, USA).</p>
<p>We adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline (<xref ref-type="bibr" rid="ref38">38</xref>). Institutional review board approval was waived for this study, which did not require informed consent, as it used deidentified, publicly available data.</p>
</sec>
</sec>
<sec sec-type="results" id="sec7">
<label>3</label>
<title>Results</title>
<p>From December 2020 to November 2021, 5,383 confirmed COVID-19 deaths were reported in the 20 designated cities. Five cities had implemented a policy to suspend the temporary revocation of eligibility for benefits; at the time of our phone confirmation, the other cities had not implemented this policy. Yokohama City implemented this policy before 2020, three cities implemented it at the beginning of 2020, and another city implemented it in August 2021. The suspension policy was implemented in four cities to equalize benefits for households in poverty and in another city to avoid management concerns (e.g., avoiding the costs involved in temporarily revoking benefits). The implementation of the suspension measure was documented in publicly released council or committee minutes for all five adopting cities, consistent with our telephone confirmations (<xref ref-type="sec" rid="sec17">Supplementary Table 1</xref>).</p>
<p>Between December 2020 and February 2021, the death rate per 1,000,000 people was 50.52 in cities that had implemented the suspension policy and 62.68 in cities that had not (<xref ref-type="table" rid="tab2">Table 2</xref>). This trend persisted in the following periods, with lower mortality rates in cities with the suspension: 30.68 versus 89.03 in the second period and 30.68 versus 44.49 in the third period. However, this trend changed in the fourth period: cities that had implemented the suspension policy had a rate of 24.68, compared with 23.32 in those that had not. We observed significantly reduced mortality in the fourth period, when vaccination coverage reached 75% of the population and plateaued (<xref ref-type="bibr" rid="ref39">39</xref>), and the difference in mortality rates between governance arrangements was lower (<xref ref-type="table" rid="tab2">Table 2</xref>).</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Comparison of city demographic and health infrastructure characteristics and COVID-19 mortality rates in four periods.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2">Characteristic</th>
<th align="center" valign="top" colspan="2">Suspension of temporary benefit revocation (<italic>n</italic>&#x202F;=&#x202F;5)</th>
<th align="center" valign="top" colspan="2">Continuation of temporary benefit revocation (<italic>n</italic>&#x202F;=&#x202F;15)</th>
</tr>
<tr>
<th align="center" valign="top">Mean</th>
<th align="center" valign="top">SD</th>
<th align="center" valign="top">Mean</th>
<th align="center" valign="top">SD</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Population&#x002A;</td>
<td align="center" valign="middle">1,733,985</td>
<td align="center" valign="middle">1,318,030</td>
<td align="center" valign="middle">1,275,275</td>
<td align="center" valign="middle">565,357</td>
</tr>
<tr>
<td align="left" valign="middle" colspan="5">COVID-19 mortality in four periods (per million)</td>
</tr>
<tr>
<td align="left" valign="middle">Dec 2020&#x2013;Feb 2021</td>
<td align="center" valign="middle">50.52</td>
<td align="center" valign="middle">22.31</td>
<td align="center" valign="middle">62.68</td>
<td align="center" valign="middle">31.86</td>
</tr>
<tr>
<td align="left" valign="middle">Mar 2021&#x2013;May 2021</td>
<td align="center" valign="middle">30.68</td>
<td align="center" valign="middle">8.47</td>
<td align="center" valign="middle">89.03</td>
<td align="center" valign="middle">85.56</td>
</tr>
<tr>
<td align="left" valign="middle">Jun 2021&#x2013;Aug 2021</td>
<td align="center" valign="middle">30.68</td>
<td align="center" valign="middle">9.48</td>
<td align="center" valign="middle">44.49</td>
<td align="center" valign="middle">29.00</td>
</tr>
<tr>
<td align="left" valign="middle">Sep 2021&#x2013;Nov 2021</td>
<td align="center" valign="middle">24.68</td>
<td align="center" valign="middle">12.08</td>
<td align="center" valign="middle">23.32</td>
<td align="center" valign="middle">11.66</td>
</tr>
<tr>
<td align="left" valign="middle">Proportion of population aged &#x2265;75&#x202F;years (%)</td>
<td align="center" valign="middle">12.72</td>
<td align="center" valign="middle">0.46</td>
<td align="center" valign="middle">13.18</td>
<td align="center" valign="middle">1.71</td>
</tr>
<tr>
<td align="left" valign="middle">Number of acute care hospital beds per population (%)</td>
<td align="center" valign="middle">0.60</td>
<td align="center" valign="middle">0.21</td>
<td align="center" valign="middle">0.69</td>
<td align="center" valign="middle">0.17</td>
</tr>
<tr>
<td align="left" valign="middle">Proportion of nursing home residents (%)</td>
<td align="center" valign="middle">0.53</td>
<td align="center" valign="middle">0.02</td>
<td align="center" valign="middle">0.56</td>
<td align="center" valign="middle">0.17</td>
</tr>
<tr>
<td align="left" valign="middle">Population density (1,000 people / km<sup>2</sup>)</td>
<td align="center" valign="middle">4.75</td>
<td align="center" valign="middle">3.14</td>
<td align="center" valign="middle">4.38</td>
<td align="center" valign="middle">2.90</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Weighted means and standard deviations (SD) are shown; the population variable was excluded.</p>
<p>&#x002A;Population ranges.</p>
<p>- Suspension of temporary benefit revocation: 3,777,491&#x2013;724,691.</p>
<p>- Continuation of temporary benefit revocation: 2,752,412&#x2013;693,389.</p>
</table-wrap-foot>
</table-wrap>
<p>The results of the negative binomial regression model are shown in <xref ref-type="table" rid="tab3">Table 3</xref>. Cities with the suspension policy had a relative mortality rate of 0.75 (95% confidence interval: 0.60&#x2013;0.94) compared with their counterpart cities that continued the revocation policy. The periodical relative mortality risks (compared with the first period) were 1.11 (0.78&#x2013;1.58) in the second period, 0.71 (0.60&#x2013;0.85) in the third period, and 0.44 (0.34&#x2013;0.58) in the fourth period. Additionally, having a greater proportion of the population aged &#x2265;75&#x202F;years was related to a higher relative risk of COVID-19 mortality of 1.37 (1.17&#x2013;1.60). A higher number of acute care hospital beds per capita was associated with a relative risk of 0.98 (0.54&#x2013;1.78). A higher proportion of nursing home residents per capita was associated with a lower relative risk of 0.05 (0.01&#x2013;0.28). Finally, greater population density was associated with a higher relative risk of 1.12 (1.08&#x2013;1.17).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Results of negative binomial regression for COVID-19 mortality in four periods (<italic>n</italic>&#x202F;=&#x202F;80).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Variable</th>
<th align="center" valign="top" colspan="2">Relative risk (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Suspension of temporary benefit revocation</td>
<td align="center" valign="top">0.75</td>
<td align="center" valign="top">(0.60&#x2013;0.94)</td>
</tr>
<tr>
<td align="left" valign="top">In four periods</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Dec 2020&#x2013;Feb 2021</td>
<td align="center" valign="middle">Ref</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Mar 2021&#x2013;May 2021</td>
<td align="center" valign="middle">1.11</td>
<td align="center" valign="top">(0.78&#x2013;1.58)</td>
</tr>
<tr>
<td align="left" valign="middle">Jun 2021&#x2013;Aug 2021</td>
<td align="center" valign="middle">0.71</td>
<td align="center" valign="top">(0.60&#x2013;0.85)</td>
</tr>
<tr>
<td align="left" valign="middle">Sep 2021&#x2013;Nov 2021</td>
<td align="center" valign="middle">0.44</td>
<td align="center" valign="top">(0.34&#x2013;0.58)</td>
</tr>
<tr>
<td align="left" valign="middle">Proportion of population aged &#x2265;75&#x202F;years (%)</td>
<td align="center" valign="middle">1.37</td>
<td align="center" valign="top">(1.17&#x2013;1.60)</td>
</tr>
<tr>
<td align="left" valign="middle">Number of acute care hospital beds per population (%)</td>
<td align="center" valign="middle">0.98</td>
<td align="center" valign="top">(0.54&#x2013;1.78)</td>
</tr>
<tr>
<td align="left" valign="middle">Proportion of nursing home residents (%)</td>
<td align="center" valign="middle">0.05</td>
<td align="center" valign="top">(0.01&#x2013;0.28)</td>
</tr>
<tr>
<td align="left" valign="middle">Population density (1,000 people / km<sup>2</sup>)</td>
<td align="center" valign="middle">1.12</td>
<td align="center" valign="top">(1.08&#x2013;1.17)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Mortality rate ratios were calculated using log (population) as the offset.</p>
<p>Robust standard errors clustered at the city level.</p>
<p>CI, confidence interval.</p>
</table-wrap-foot>
</table-wrap>
<p>We assessed robustness using equivalized disposable household income, Poisson regression, exclusion of the two largest cities, and diagnostics for multicollinearity. All sensitivity checks yielded essentially similar inferences (<xref ref-type="sec" rid="sec17">Supplementary Tables 2&#x2013;5</xref>).</p>
</sec>
<sec sec-type="discussion" id="sec8">
<label>4</label>
<title>Discussion</title>
<p>The current study identified an association between municipality adoption of the suspension of temporary benefit eligibility revocation under the national health insurance system and lower COVID-19 mortality, adjusting for period, demographics, healthcare resources, and population density. The results suggest that cities with administrative governance frameworks for coordinated policymaking demonstrated better management of COVID-19 mortality compared with their counterpart cities. The findings align with the results of previous national-level studies, and indicate that governance may affect population health outcomes (<xref ref-type="bibr" rid="ref10">10</xref>).</p>
<p>The observed mortality differences were unlikely to be attributable to the suspension policy per se for several reasons. First, only approximately 0.2% of the total households in Japan are subject to temporary benefit revocation (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref28">28</xref>); this percentage is too small to explain the magnitude of the estimated risk ratio. Additionally, medical visits related to COVID-19 were subsidized for households in poverty during the study period (<xref ref-type="bibr" rid="ref29">29</xref>); thus, it is unlikely that poorer households subject to the temporary revocation had very high case fatalities.</p>
<p>The political ideology of state chief executives may lead to different stringent policy choices, as observed in the USA (<xref ref-type="bibr" rid="ref6">6</xref>). In our sample cities, five mayors who implemented the policy ran for the post of mayor without any party affiliation, and four mayors were considered to be conservatives (<xref ref-type="bibr" rid="ref40 ref41 ref42 ref43 ref44 ref45">40&#x2013;45</xref>). Thus, it is not necessarily the case that the suspension policy decision was based on an ideology of liberalism/welfarism. Moreover, governance arrangements, regardless of the political ideology of the leader, often require balanced management of the various values and interests of stakeholders (<xref ref-type="bibr" rid="ref46">46</xref>, <xref ref-type="bibr" rid="ref47">47</xref>).</p>
<p>Regarding the covariates included in the model, a higher proportion of nursing home residents per capita was associated with lower municipal mortality. This association is counterintuitive, but is consistent with the prioritization of early vaccination for long-term care residents and staff in Japan, along with facility-level controls (such as restricted visits and outings) that disproportionately protected this group (<xref ref-type="bibr" rid="ref48">48</xref>, <xref ref-type="bibr" rid="ref49">49</xref>). Given the ecological design, we interpret this as a population-level association rather than individual protection. Higher mortality rates were observed in those regions that contained more people aged &#x2265;75&#x202F;years and those with denser populations, which is consistent with previous findings (<xref ref-type="bibr" rid="ref50">50</xref>, <xref ref-type="bibr" rid="ref51">51</xref>).</p>
<p>The COVID-19 vaccination program in Japan was rolled out in phases, beginning with healthcare workers in February 2021 and expanding to older adults and other high-risk groups from April 2021 (<xref ref-type="bibr" rid="ref48">48</xref>). Our data showed that between-group mortality differences narrowed in the fourth period, indicating that any association with the suspension policy arose primarily pre-vaccination. This pattern is consistent with US evidence that vaccination attenuated partisan differences in excess mortality (<xref ref-type="bibr" rid="ref52">52</xref>) and suggests that collaborative governance&#x2014;for case tracing and triage&#x2014;mattered most in the early pandemic phase when there was considerable uncertainty (<xref ref-type="bibr" rid="ref31">31</xref>).</p>
<p>Governance arrangements affect the formation of healthcare systems (<xref ref-type="bibr" rid="ref53">53</xref>). The results of the current study suggest several pathways by which local governance arrangements resulted in population health outcomes during the pandemic. During the pandemic period, local public health centers were the focus of coordination with healthcare facilities and other entities for managing hospitalizations, health monitoring, and contact tracing of COVID-19 patients during case surges. However, many centers were stretched beyond capacity by the rapid increase in cases (<xref ref-type="bibr" rid="ref16">16</xref>). Healthcare facilities also were challenged by the limited number of beds and medical staff to care for COVID-19 inpatients, and had to reallocate their treatment provision from patients with other diseases to those with COVID-19 (<xref ref-type="bibr" rid="ref54">54</xref>). Some local governments addressed these difficulties by sharing data on hospitalized COVID-19 patients and available beds using a unified assessment scale for hospital admissions in coordination with healthcare providers and public health centers, as well as using information and communications technology to monitor mild cases (<xref ref-type="bibr" rid="ref54">54</xref>). These flexible measures required reallocating staff from various departments and collaborating with healthcare institutions, health and non-health sectors of local governments, and private hospitals. Our results indicate that successful governance arrangements involved efficient resource allocation and information sharing to effectively manage the surge in cases.</p>
<p>Similar challenges in organizing local and regional responses to COVID-19 have been reported outside Japan (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref5 ref6 ref7">5&#x2013;7</xref>, <xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref55 ref56 ref57 ref58 ref59 ref60 ref61">55&#x2013;61</xref>). These examples also highlight the importance of coordinating health and social policies across sectors when responding to population health challenges during the pandemic. The current study, although limited to analysis of city-level data from Japan, suggests that similar mechanisms might operate at national and international levels. However, it remains unclear who benefits most from governance differences. To enable more systematic comparisons across contexts, future work should refine and extend indicators of multifaceted governance; for example, by constructing comparable measures based on publicly visible policy decisions in other countries. Such indicators could be used to examine how collaborative governance shapes key social determinants of health and contributes to widening or narrowing socioeconomic disparities in mortality and access to care.</p>
<sec id="sec9">
<label>4.1</label>
<title>Limitations</title>
<p>This study had several limitations. First, the design was cross-sectional and ecological at the municipal level; therefore, causal relationships cannot be inferred and the findings are not interpretable at the individual level. Given the limited sample size and the likelihood of residual or unmeasured confounding, as well as potential policy endogeneity and reverse causation, the observed patterns should be viewed as associations and as indicators that help to generate future hypotheses. Second, categorizing governance arrangements according to a single policy may have led to problems with misclassification. Although other municipal-level indicators of collaborative governance may exist, in this setting we considered the suspension policy a practice-grounded proxy for municipal collaborative governance; broader indicator sets should be developed in future studies. Four cities implemented the policy before the observation period, and one city during this period. Additionally, 2 of the 20 designated cities changed mayors during the observation period (<xref ref-type="bibr" rid="ref42">42</xref>). However, substantial changes in governance arrangements may require an extended period, such as &#x2265;5&#x202F;years, and we believe there were no good reasons for major governance style changes to occur during the observed 2-year window (<xref ref-type="bibr" rid="ref33">33</xref>). Third, although socioeconomic status was not included in the primary adjustment set, we conducted a sensitivity analysis by adding a city-level socioeconomic status proxy&#x2014;equivalized disposable household income per capita&#x2014;and the results were essentially unchanged (<xref ref-type="sec" rid="sec17">Supplementary Table 2</xref>). A previous study identified associations between socioeconomic status and COVID-19-related mortality and incidence at the prefecture level in Japan; in particular, a higher unemployment rate was proportionally linked to higher mortality (<xref ref-type="bibr" rid="ref13">13</xref>). However, the differences in unemployment rates across the 20 cities were less pronounced than the differences across the prefectures (<xref ref-type="bibr" rid="ref27">27</xref>). Therefore, although the sensitivity analysis reduces concerns about confounding among socioeconomic status variables, the presence of some residual confounding cannot be ruled out. Fourth, this study included only 20 ordinance-designated cities, which typically have greater administrative and public health capacities than smaller municipalities. It may not be possible to generalize the findings to smaller Japanese municipalities, prefectural public health center jurisdictions, and international settings; the coordination mechanisms we propose may be transferable, but effect sizes are likely to depend on local capacity, provider market structure, and legal authority. Finally, owing to the lack of disaggregated data, we compared crude rates of COVID-19-related mortality, which may have ignored important variations in sex and age distributions among city populations.</p>
</sec>
</sec>
<sec sec-type="conclusions" id="sec10">
<label>5</label>
<title>Conclusion</title>
<p>In this study, we identified a correlation between the policy of suspending temporary benefits under the national health insurance system of Japan and reduced COVID-19 mortality at the city level. Our findings indicate the potential effectiveness of governance arrangements in providing public health services. Further research is recommended to explore the mediating pathways by which governance arrangements affect public health, and to develop governance arrangement indicators.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec11">
<title>Data availability statement</title>
<p>All the data used in this study are publicly available from the cited databases. The telephone survey results are included in the manuscript and <xref ref-type="sec" rid="sec17">Supplementary Table 1</xref>.</p>
</sec>
<sec sec-type="ethics-statement" id="sec12">
<title>Ethics statement</title>
<p>Ethical review and approval was waived by the Institutional Review Board of the Graduate School of Medicine, The University of Tokyo, because this study used de-identified, publicly available data and did not require informed consent. The study was conducted in accordance with local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec13">
<title>Author contributions</title>
<p>YN: Conceptualization, Writing &#x2013; review &#x0026; editing, Methodology, Writing &#x2013; original draft, Investigation, Visualization, Formal analysis. HH: Conceptualization, Writing &#x2013; review &#x0026; editing, Methodology, Supervision.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We would like to express our gratitude to the various city hall officials who participated in the telephone interviews for this research.</p>
</ack>
<sec sec-type="COI-statement" id="sec14">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author HH declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="sec15">
<title>Generative AI statement</title>
<p>The author(s) declared that Generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec16">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec17">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fpubh.2025.1622066/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fpubh.2025.1622066/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.docx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_3.docx" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_4.docx" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_5.docx" id="SM5" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll1">World Health Organization</collab></person-group>. <source>Closing the gap in a generation: Health equity through action on the social determinants of health (2008)</source>. <publisher-name>World Health Organization</publisher-name>. Available online at: <ext-link xlink:href="https://iris.who.int/bitstream/handle/10665/43943/9789241563703_eng.pdf" ext-link-type="uri">https://iris.who.int/bitstream/handle/10665/43943/9789241563703_eng.pdf</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>GA</given-names></name> <name><surname>Pamuk</surname><given-names>ER</given-names></name> <name><surname>Lynch</surname><given-names>JW</given-names></name> <name><surname>Cohen</surname><given-names>RD</given-names></name> <name><surname>Balfour</surname><given-names>JL</given-names></name></person-group>. <article-title>Inequality in income and mortality in the United States: analysis of mortality and potential pathways</article-title>. <source>BMJ</source>. (<year>1996</year>) <volume>312</volume>:<fpage>999</fpage>&#x2013;<lpage>1003</lpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.312.7037.999</pub-id>, <pub-id pub-id-type="pmid">8616393</pub-id></mixed-citation></ref>
<ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehgal</surname><given-names>NJ</given-names></name> <name><surname>Yue</surname><given-names>D</given-names></name> <name><surname>Pope</surname><given-names>E</given-names></name> <name><surname>Wang</surname><given-names>RH</given-names></name> <name><surname>Roby</surname><given-names>DH</given-names></name></person-group>. <article-title>The association between COVID-19 mortality and the county-level partisan divide in the United States</article-title>. <source>Health Aff</source>. (<year>2022</year>) <volume>41</volume>:<fpage>853</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1377/hlthaff.2022.00085</pub-id></mixed-citation></ref>
<ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibuya</surname><given-names>K</given-names></name> <name><surname>Hashimoto</surname><given-names>H</given-names></name> <name><surname>Yano</surname><given-names>E</given-names></name></person-group>. <article-title>Individual income, income distribution, and self rated health in Japan: cross sectional analysis of nationally representative sample</article-title>. <source>BMJ</source>. (<year>2002</year>) <volume>324</volume>:<fpage>16</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.324.7328.16</pub-id>, <pub-id pub-id-type="pmid">11777798</pub-id></mixed-citation></ref>
<ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>SH</given-names></name></person-group>. <article-title>The growing influence of state governments on population health in the United States</article-title>. <source>JAMA</source>. (<year>2022</year>) <volume>327</volume>:<fpage>1331</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2022.3785</pub-id>, <pub-id pub-id-type="pmid">35275203</pub-id></mixed-citation></ref>
<ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neelon</surname><given-names>B</given-names></name> <name><surname>Mutiso</surname><given-names>F</given-names></name> <name><surname>Mueller</surname><given-names>NT</given-names></name> <name><surname>Pearce</surname><given-names>JL</given-names></name> <name><surname>Benjamin-Neelon</surname><given-names>SE</given-names></name></person-group>. <article-title>Associations between governor political affiliation and COVID-19 cases, deaths, and testing in the U.S</article-title>. <source>Am J Prev Med</source>. (<year>2021</year>) <volume>61</volume>:<fpage>115</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amepre.2021.01.034</pub-id>, <pub-id pub-id-type="pmid">33775513</pub-id></mixed-citation></ref>
<ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shvetsova</surname><given-names>O</given-names></name> <name><surname>Zhirnov</surname><given-names>A</given-names></name> <name><surname>Giannelli</surname><given-names>FR</given-names></name> <name><surname>Catalano</surname><given-names>MA</given-names></name> <name><surname>Catalano</surname><given-names>O</given-names></name></person-group>. <article-title>Governor&#x2019;s party, policies, and COVID-19 outcomes: further evidence of an effect</article-title>. <source>Am J Prev Med</source>. (<year>2022</year>) <volume>62</volume>:<fpage>433</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amepre.2021.09.003</pub-id>, <pub-id pub-id-type="pmid">34756754</pub-id></mixed-citation></ref>
<ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalloh</surname><given-names>MF</given-names></name> <name><surname>Zeebari</surname><given-names>Z</given-names></name> <name><surname>Nur</surname><given-names>SA</given-names></name> <name><surname>Prybylski</surname><given-names>D</given-names></name> <name><surname>Nur</surname><given-names>AA</given-names></name> <name><surname>Hakim</surname><given-names>AJ</given-names></name> <etal/></person-group>. <article-title>Drivers of COVID-19 policy stringency in 175 countries and territories: COVID-19 cases and deaths, gross domestic products per capita, and health expenditures</article-title>. <source>J Glob Health</source>. (<year>2022</year>) <volume>12</volume>:<fpage>05049</fpage>. doi: <pub-id pub-id-type="doi">10.7189/jogh.12.05049</pub-id>, <pub-id pub-id-type="pmid">36527269</pub-id></mixed-citation></ref>
<ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>K</given-names></name> <name><surname>Jaswal</surname><given-names>V</given-names></name> <name><surname>Pandey</surname><given-names>AK</given-names></name> <name><surname>Verma</surname><given-names>M</given-names></name> <name><surname>Koushal</surname><given-names>V</given-names></name></person-group>. <article-title>Utility of the comprehensive health and stringency indexes in evaluating government responses for containing the spread of COVID-19 in India: ecological time-series study</article-title>. <source>JMIR Public Health Surveill</source>. (<year>2023</year>) <volume>9</volume>:<fpage>e38371</fpage>. doi: <pub-id pub-id-type="doi">10.2196/38371</pub-id>, <pub-id pub-id-type="pmid">36395334</pub-id></mixed-citation></ref>
<ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagschal</surname><given-names>U</given-names></name></person-group>. <article-title>The influence of democracy, governance and government policies on the COVID-19 pandemic mortality</article-title>. <source>Eur Policy Anal</source>. (<year>2022</year>) <volume>8</volume>:<fpage>231</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1002/epa2.1146</pub-id>, <pub-id pub-id-type="pmid">35937045</pub-id></mixed-citation></ref>
<ref id="ref11"><label>11.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll2">Johns Hopkins Coronavirus Resource Center</collab></person-group>. Mortality analyses (<year>n.d.</year>). Available online at: <ext-link xlink:href="https://coronavirus.jhu.edu/data/mortality" ext-link-type="uri">https://coronavirus.jhu.edu/data/mortality</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beppu</surname><given-names>M</given-names></name> <name><surname>Hayashi</surname><given-names>R</given-names></name></person-group>. <article-title>COVID-19 related deaths in Japan</article-title>. <source>IPSS Res Rep</source>. (<year>2022</year>). doi: <pub-id pub-id-type="doi">10.50870/00000357</pub-id></mixed-citation></ref>
<ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname><given-names>Y</given-names></name> <name><surname>Kawachi</surname><given-names>I</given-names></name></person-group>. <article-title>Association of socioeconomic characteristics with disparities in COVID-19 outcomes in Japan</article-title>. <source>JAMA Netw Open</source>. (<year>2021</year>) <volume>4</volume>:<fpage>e2117060</fpage>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.17060</pub-id>, <pub-id pub-id-type="pmid">34259847</pub-id></mixed-citation></ref>
<ref id="ref14"><label>14.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll3">Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine</collab></person-group>. <source>Number of new coronavirus deaths per population by prefecture</source> (<year>n.d.</year>). Available online at: <ext-link xlink:href="https://web.sapmed.ac.jp/canmol/coronavirus/japan_death.html" ext-link-type="uri">https://web.sapmed.ac.jp/canmol/coronavirus/japan_death.html</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref15"><label>15.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Yoshizaki</surname><given-names>H</given-names></name></person-group>. <source>Worst: No. 1 Osaka, no. 2 Kyoto, and Kochi surpass Tokyo; Okinawa surprisingly ranked 41st; COVID-19 mortality in 47 prefectures in Japan (in Japanese)</source>. <publisher-loc>Tokyo, Japan</publisher-loc>: <publisher-name>AERA dot</publisher-name>. (<year>2022</year>). Available online at: <ext-link xlink:href="https://dot.asahi.com/articles/-/41877" ext-link-type="uri">https://dot.asahi.com/articles/-/41877</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirai</surname><given-names>C</given-names></name> <name><surname>Uchida</surname><given-names>K</given-names></name> <name><surname>Seiko</surname><given-names>A</given-names></name> <name><surname>Fujita</surname><given-names>R</given-names></name> <name><surname>Uetani</surname><given-names>K</given-names></name> <name><surname>Kimura</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>The response of local governments and public health centers to COVID-19: looking for infectious disease control due to the change of trend and mutations of the virus (in Japanese)</article-title>. <source>J Natl Inst Public Health</source>. (<year>2022</year>) <volume>71</volume>:<fpage>292</fpage>&#x2013;<lpage>304</lpage>. doi: <pub-id pub-id-type="doi">10.20683/jniph.71.4_292</pub-id></mixed-citation></ref>
<ref id="ref17"><label>17.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll4">NHK</collab></person-group>. <source>Countermeasure for COVID-19 in local governance: Perspectives and issues</source> (<year>2020</year>). Available online at: <ext-link xlink:href="https://www.nhk.jp/p/ts/Y5P47Z7YVW/episode/te/DJGPR6XX49/" ext-link-type="uri">https://www.nhk.jp/p/ts/Y5P47Z7YVW/episode/te/DJGPR6XX49/</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>A</given-names></name> <name><surname>Fischer</surname><given-names>HW</given-names></name></person-group>. <article-title>The local governance of COVID-19: disease prevention and social security in rural India</article-title>. <source>World Dev</source>. (<year>2021</year>) <volume>138</volume>:<fpage>105234</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.worlddev.2020.105234</pub-id>, <pub-id pub-id-type="pmid">33106724</pub-id></mixed-citation></ref>
<ref id="ref19"><label>19.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll5">Council of Local Authorities for International Relations</collab></person-group>. <source>Local government in Japan 2020 (2022 revised edition)</source> (<year>2023</year>). Available online at: <ext-link xlink:href="https://www.clair.or.jp/j/forum/pub/docs/jichi2022-en.pdf" ext-link-type="uri">https://www.clair.or.jp/j/forum/pub/docs/jichi2022-en.pdf</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref20"><label>20.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>S</given-names></name></person-group>. <article-title>Decentralization in Japan</article-title> In: <person-group person-group-type="editor"><name><surname>Furukawa</surname><given-names>S</given-names></name> <name><surname>Menju</surname><given-names>T</given-names></name></person-group>, editors. <source>Japan&#x2019;s road to pluralism: Transforming local communities in the global era</source>. <publisher-loc>Tokyo</publisher-loc>: <publisher-name>Japan Center for International Exchange</publisher-name> (<year>2003</year>). <fpage>21</fpage>&#x2013;<lpage>45</lpage>.</mixed-citation></ref>
<ref id="ref21"><label>21.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>D</given-names></name> <name><surname>Kraay</surname><given-names>A</given-names></name> <name><surname>Mastruzzi</surname><given-names>M</given-names></name></person-group>. <article-title>The worldwide governance indicators: methodology and analytical issues</article-title> (<year>2010</year>). doi: <pub-id pub-id-type="doi">10.1596/1813-9450-5430</pub-id>,</mixed-citation></ref>
<ref id="ref22"><label>22.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll6">World Bank Group</collab></person-group>. <source>Worldwide governance indicators</source> (<year>n.d.</year>). Available online at: <ext-link xlink:href="https://www.worldbank.org/en/publication/worldwide-governance-indicators" ext-link-type="uri">https://www.worldbank.org/en/publication/worldwide-governance-indicators</ext-link> (Accessed October 23, 2024).</mixed-citation></ref>
<ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegami</surname><given-names>N</given-names></name> <name><surname>Yoo</surname><given-names>B-K</given-names></name> <name><surname>Hashimoto</surname><given-names>H</given-names></name> <name><surname>Matsumoto</surname><given-names>M</given-names></name> <name><surname>Ogata</surname><given-names>H</given-names></name> <name><surname>Babazono</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Japanese universal health coverage: evolution, achievements, and challenges</article-title>. <source>Lancet</source>. (<year>2011</year>) <volume>378</volume>:<fpage>1106</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(11)60828-3</pub-id>, <pub-id pub-id-type="pmid">21885107</pub-id></mixed-citation></ref>
<ref id="ref24"><label>24.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll7">Government of Japan</collab></person-group>. National Health Insurance Act. Law No. 192 of 1958. e-Gov Laws &#x0026; Regulations Database. Available online at: <ext-link xlink:href="https://laws.e-gov.go.jp/law/333AC0000000192/20241001_506AC0000000047" ext-link-type="uri">https://laws.e-gov.go.jp/law/333AC0000000192/20241001_506AC0000000047</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref25"><label>25.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll8">Government of Japan. Local Autonomy Act</collab></person-group>. Law No. 67 of 1947. e-Gov Laws &#x0026; Regulations Database. Available online at: <ext-link xlink:href="https://laws.e-gov.go.jp/law/322AC0000000067" ext-link-type="uri">https://laws.e-gov.go.jp/law/322AC0000000067</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emerson</surname><given-names>K</given-names></name> <name><surname>Nabatchi</surname><given-names>T</given-names></name> <name><surname>Balogh</surname><given-names>S</given-names></name></person-group>. <article-title>An integrative framework for collaborative governance</article-title>. <source>J Public Adm Res Theory</source>. (<year>2012</year>) <volume>22</volume>:<fpage>1</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jopart/mur011</pub-id></mixed-citation></ref>
<ref id="ref27"><label>27.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll9">Ministry of Internal Affairs and Communications</collab></person-group>. Population census 2020 (<year>2021</year>). Available online at: <ext-link xlink:href="https://www.stat.go.jp/english/data/kokusei/2020/summary.html" ext-link-type="uri">https://www.stat.go.jp/english/data/kokusei/2020/summary.html</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref28"><label>28.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll10">Ministry of Health, Labour and Welfare</collab></person-group>. <source>Report on the state of national health insurance operations 2020</source> (<year>2022</year>). Available online at: <ext-link xlink:href="https://www.e-stat.go.jp/stat-search/files?page=1&#x0026;toukei=00450397&#x0026;tstat=000001162393" ext-link-type="uri">https://www.e-stat.go.jp/stat-search/files?page=1&#x0026;toukei=00450397&#x0026;tstat=000001162393</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref29"><label>29.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll11">Ministry of Health, Labour and Welfare</collab></person-group>. <source>Guidelines for the handling of health insurance certificates during visits to medical institutions for diagnosis and testing related to COVID-19 infection</source> (<year>2020</year>). Available online at: <ext-link xlink:href="https://www.mhlw.go.jp/content/000700096.pdf" ext-link-type="uri">https://www.mhlw.go.jp/content/000700096.pdf</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtsu</surname><given-names>Y</given-names></name> <name><surname>Yamada</surname><given-names>A</given-names></name> <name><surname>Izumida</surname><given-names>N</given-names></name></person-group>. <article-title>The impact of short-term health insurance card and eligibility certification card on health care access in Japan: findings from national health insurance receipt data (in Japanese)</article-title>. <source>Jpn J Health Econ Policy</source>. (<year>2013</year>) <volume>25</volume>:<fpage>33</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.24742/jhep.2013.04</pub-id></mixed-citation></ref>
<ref id="ref31"><label>31.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Shiroyama</surname><given-names>H</given-names></name> <name><surname>Osaka</surname><given-names>K</given-names></name> <name><surname>Somae</surname><given-names>K</given-names></name> <name><surname>Yamabe</surname><given-names>M</given-names></name></person-group>. <source>Governance for health emergency management: Lessons from COVID-19</source> (<year>2024</year>). Public Interest Incorporated Foundation Health Care Science Institute. Available online at: <ext-link xlink:href="https://www.iken.org/project/project05/files/2024.pdf" ext-link-type="uri">https://www.iken.org/project/project05/files/2024.pdf</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref32"><label>32.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll12">Ministry of Health, Labour and Welfare</collab></person-group>. (<year>n.d.</year>) Vital statistics. Available online at: <ext-link xlink:href="https://www.mhlw.go.jp/toukei/list/81-1.html" ext-link-type="uri">https://www.mhlw.go.jp/toukei/list/81-1.html</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref33"><label>33.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pollitt</surname><given-names>C</given-names></name> <name><surname>Bouckaert</surname><given-names>G</given-names></name></person-group>. <article-title>Reflection</article-title> In: <person-group person-group-type="editor"><name><surname>Pollitt</surname><given-names>C</given-names></name> <name><surname>Bouckaert</surname><given-names>G</given-names></name></person-group>, editors. <source>Public management reform: A comparative analysis&#x2014;Into the age of austerity</source>. <edition>4th</edition> ed. <publisher-loc>Oxford; New York</publisher-loc>: <publisher-name>Oxford University Press</publisher-name> (<year>2017</year>). <fpage>165</fpage>&#x2013;<lpage>85</lpage>.</mixed-citation></ref>
<ref id="ref34"><label>34.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll20">Yokohama City Office</collab></person-group>. (<year>n.d.</year>) Comparative statistical tables for large cities 2021. Available online at: <ext-link xlink:href="https://www.city.yokohama.lg.jp/city-info/yokohamashi/tokei-chosa/portal/nenpyo/d-r3.html" ext-link-type="uri">https://www.city.yokohama.lg.jp/city-info/yokohamashi/tokei-chosa/portal/nenpyo/d-r3.html</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref35"><label>35.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll21">Ministry of Health, Labour and Welfare</collab></person-group>. (<year>2022</year>). Report on the state of long-term care insurance operations 2020. Available online at: <ext-link xlink:href="https://www.mhlw.go.jp/toukei/list/84-1.html" ext-link-type="uri">https://www.mhlw.go.jp/toukei/list/84-1.html</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref36"><label>36.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll22">Ministry of Internal Affairs and Communications</collab></person-group>. System of social and demographic statistics, statistical observations of municipalities 2020 basic data. Portal Site of Official Statistics of Japan (<year>2020</year>). Available online at: <ext-link xlink:href="https://www.e-stat.go.jp/en/stat-search/files?page=1&#x0026;layout=datalist&#x0026;toukei=00200502&#x0026;tstat=000001141146&#x0026;cycle=0&#x0026;tclass1=000001141147&#x0026;cycle_facet=cycle&#x0026;tclass2val=0&#x0026;metadata=1&#x0026;data=1" ext-link-type="uri">https://www.e-stat.go.jp/en/stat-search/files?page=1&#x0026;layout=datalist&#x0026;toukei=00200502&#x0026;tstat=000001141146&#x0026;cycle=0&#x0026;tclass1=000001141147&#x0026;cycle_facet=cycle&#x0026;tclass2val=0&#x0026;metadata=1&#x0026;data=1</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>AC</given-names></name> <name><surname>Trivedi</surname><given-names>PK</given-names></name></person-group>. <article-title>Econometric models based on count data: comparisons and applications of some estimators and tests</article-title>. <source>J Appl Econ</source>. (<year>1986</year>) <volume>1</volume>:<fpage>29</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jae.3950010104</pub-id></mixed-citation></ref>
<ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Elm</surname><given-names>E</given-names></name> <name><surname>Altman</surname><given-names>DG</given-names></name> <name><surname>Egger</surname><given-names>M</given-names></name> <name><surname>Pocock</surname><given-names>SJ</given-names></name> <name><surname>G&#x00F8;tzsche</surname><given-names>PC</given-names></name> <name><surname>Vandenbroucke</surname><given-names>JP</given-names></name></person-group>. <article-title>The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>J Clin Epidemiol</source>. (<year>2008</year>) <volume>61</volume>:<fpage>344</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jclinepi.2007.11.008</pub-id>, <pub-id pub-id-type="pmid">18313558</pub-id></mixed-citation></ref>
<ref id="ref39"><label>39.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll13">Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine</collab></person-group>. <year>2025</year> Vaccination coverage for new coronavirus vaccine by prefecture. Available online at: <ext-link xlink:href="https://web.sapmed.ac.jp/canmol/coronavirus/japan_vaccine.html" ext-link-type="uri">https://web.sapmed.ac.jp/canmol/coronavirus/japan_vaccine.html</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref40"><label>40.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll14">Nikkei</collab></person-group>. (<year>2023</year>). Mayor Kawamura of Nagoya becomes co-chairman of the Japan Conservative Party. Available online at: <ext-link xlink:href="https://www.nikkei.com/article/DGXZQOUA179PF0X11C23A0000000/" ext-link-type="uri">https://www.nikkei.com/article/DGXZQOUA179PF0X11C23A0000000/</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref41"><label>41.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll15">Ministry of Internal Affairs and Communications</collab></person-group>. (<year>n.d.</year>). Municipal election results record. Available online at: <ext-link xlink:href="https://www.soumu.go.jp/senkyo/senkyo_s/data/chihou/index.html" ext-link-type="uri">https://www.soumu.go.jp/senkyo/senkyo_s/data/chihou/index.html</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref42"><label>42.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll16">Ministry of Internal Affairs and Communications</collab></person-group>. (<year>n.d.</year>). Election results for mayors of cities designated by the government ordinance. Available online at: <ext-link xlink:href="https://www.soumu.go.jp/senkyo/senkyo_s/data/shityou/index.html" ext-link-type="uri">https://www.soumu.go.jp/senkyo/senkyo_s/data/shityou/index.html</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref43"><label>43.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll17">Nikkei</collab></person-group>. (<year>2021</year>). Yokohama mayoral election announced; 8 candidates run. Available online at: <ext-link xlink:href="https://www.nikkei.com/article/DGXZQODE296YN0Z20C21A7000000/" ext-link-type="uri">https://www.nikkei.com/article/DGXZQODE296YN0Z20C21A7000000/</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref44"><label>44.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll18">Okayama Broadcasting</collab></person-group>. (<year>2021</year>). Citizens choose. <ext-link xlink:href="https://www.ohk.co.jp/data/12531/pages/" ext-link-type="uri">https://www.ohk.co.jp/data/12531/pages/</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref45"><label>45.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll19">Sankei Shimbun</collab></person-group>. (<year>2014</year>). Two weeks until the Kumamoto mayoral election. Available online at: <ext-link xlink:href="https://www.sankei.com/article/20141020-WW4BUGIRORJ7VPYVLEAW2QWBAE/" ext-link-type="uri">https://www.sankei.com/article/20141020-WW4BUGIRORJ7VPYVLEAW2QWBAE/</ext-link> (Accessed October 23, 2025).</mixed-citation></ref>
<ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mintzberg</surname><given-names>H</given-names></name></person-group>. <article-title>Managing government, governing management</article-title>. <source>Harv Bus Rev</source>. (<year>1996</year>) <volume>74</volume>:<fpage>75</fpage>&#x2013;<lpage>83</lpage>.</mixed-citation></ref>
<ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollitt</surname><given-names>C</given-names></name></person-group>. <article-title>Managerialism redux?</article-title> <source>Fin Acc Manag</source>. (<year>2016</year>) <volume>32</volume>:<fpage>429</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1111/faam.12094</pub-id></mixed-citation></ref>
<ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>S</given-names></name></person-group>. <article-title>Overall picture of the COVID-19 vaccination program in Japan (in Japanese)</article-title>. <source>J Natl Inst Public Health</source>. (<year>2022</year>) <volume>71</volume>:<fpage>335</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.20683/jniph.71.4_335</pub-id></mixed-citation></ref>
<ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazawa</surname><given-names>K</given-names></name> <name><surname>Kubo</surname><given-names>T</given-names></name> <name><surname>Akishita</surname><given-names>M</given-names></name> <name><surname>Ishii</surname><given-names>S</given-names></name></person-group>. <article-title>Restrictions on visits and outings in geriatric care facilities during the COVID-19 pandemic</article-title>. <source>Geriatr Gerontol Int</source>. (<year>2022</year>) <volume>22</volume>:<fpage>982</fpage>&#x2013;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ggi.14484</pub-id>, <pub-id pub-id-type="pmid">36151770</pub-id></mixed-citation></ref>
<ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharif</surname><given-names>N</given-names></name> <name><surname>Ahmed</surname><given-names>SN</given-names></name> <name><surname>Opu</surname><given-names>RR</given-names></name> <name><surname>Daullah</surname><given-names>MU</given-names></name> <name><surname>Khan</surname><given-names>S</given-names></name> <name><surname>Talukder</surname><given-names>AA</given-names></name> <etal/></person-group>. <article-title>Impact of meteorological parameters and population density on variants of <italic>SARS-CoV-2</italic> and outcome of COVID-19 pandemic in Japan</article-title>. <source>Epidemiol Infect</source>. (<year>2021</year>) <volume>149</volume>:<fpage>e103</fpage>. doi: <pub-id pub-id-type="doi">10.1017/S095026882100100X</pub-id>, <pub-id pub-id-type="pmid">33908339</pub-id></mixed-citation></ref>
<ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>Y</given-names></name> <name><surname>Kuno</surname><given-names>T</given-names></name> <name><surname>Komiyama</surname><given-names>J</given-names></name> <name><surname>Adomi</surname><given-names>M</given-names></name> <name><surname>Suzuki</surname><given-names>T</given-names></name> <name><surname>Abe</surname><given-names>T</given-names></name> <etal/></person-group>. <article-title>Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan</article-title>. <source>Lancet Reg Health West Pac</source>. (<year>2022</year>) <volume>20</volume>:<fpage>100365</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lanwpc.2021.100365</pub-id>, <pub-id pub-id-type="pmid">35005672</pub-id></mixed-citation></ref>
<ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>J</given-names></name> <name><surname>Goldsmith-Pinkham</surname><given-names>P</given-names></name> <name><surname>Schwartz</surname><given-names>JL</given-names></name></person-group>. <article-title>Excess death rates for republican and democratic registered voters in Florida and Ohio during the COVID-19 pandemic</article-title>. <source>JAMA Intern Med</source>. (<year>2023</year>) <volume>183</volume>:<fpage>916</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamainternmed.2023.1154</pub-id>, <pub-id pub-id-type="pmid">37486680</pub-id></mixed-citation></ref>
<ref id="ref53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenbensel</surname><given-names>T</given-names></name> <name><surname>Silwal</surname><given-names>P</given-names></name> <name><surname>Walton</surname><given-names>L</given-names></name></person-group>. <article-title>Overwriting new public management with new public governance in New Zealand&#x2019;s approach to health system improvement</article-title>. <source>J Health Organ Manag</source>. (<year>2021</year>) <volume>35</volume>:<fpage>1046</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1108/JHOM-10-2020-0417</pub-id></mixed-citation></ref>
<ref id="ref54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anan</surname><given-names>H</given-names></name></person-group>. <article-title>Review and future prospects of the medical system for COVID-19</article-title>. <source>J Natl Inst Public Health.</source> (<year>2022</year>) <volume>71</volume>:<fpage>324</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.20683/jniph.71.4_324</pub-id></mixed-citation></ref>
<ref id="ref55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>FP</given-names></name> <name><surname>Cuscianna</surname><given-names>E</given-names></name> <name><surname>Di Lorenzo</surname><given-names>A</given-names></name> <name><surname>Daleno</surname><given-names>A</given-names></name> <name><surname>Mele</surname><given-names>F</given-names></name> <name><surname>Marra</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>A new paradigm of hospital care for SARS-COV-2 patients in the post-emergency phase in Italy</article-title>. <source>Ann Ig</source>. (<year>2023</year>) <volume>35</volume>:<fpage>250</fpage>&#x2013;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.7416/ai.2022.2546</pub-id>, <pub-id pub-id-type="pmid">36222605</pub-id></mixed-citation></ref>
<ref id="ref56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>FP</given-names></name> <name><surname>Stefanizzi</surname><given-names>P</given-names></name> <name><surname>Cuscianna</surname><given-names>E</given-names></name> <name><surname>Riformato</surname><given-names>G</given-names></name> <name><surname>Di Lorenzo</surname><given-names>A</given-names></name> <name><surname>Giordano</surname><given-names>P</given-names></name> <etal/></person-group>. <article-title>COVID-19 vaccination hesitancy among Italian parents: a systematic review and meta-analysis</article-title>. <source>Hum Vaccin Immunother</source>. (<year>2023</year>) <volume>19</volume>:<fpage>2171185</fpage>. doi: <pub-id pub-id-type="doi">10.1080/21645515.2023.2171185</pub-id>, <pub-id pub-id-type="pmid">36698309</pub-id></mixed-citation></ref>
<ref id="ref57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>FP</given-names></name> <name><surname>Stefanizzi</surname><given-names>P</given-names></name> <name><surname>Di Lorenzo</surname><given-names>A</given-names></name> <name><surname>Cuscianna</surname><given-names>E</given-names></name> <name><surname>Tafuri</surname><given-names>S</given-names></name> <name><surname>Germinario</surname><given-names>CA</given-names></name></person-group>. <article-title>Vaccine coverage for recommended vaccines among splenectomised patients in Apulia, South Italy: a retrospective cohort study</article-title>. <source>BMJ Open</source>. (<year>2023</year>) <volume>13</volume>:<fpage>e069316</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2022-069316</pub-id>, <pub-id pub-id-type="pmid">36990496</pub-id></mixed-citation></ref>
<ref id="ref58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>FP</given-names></name> <name><surname>Stefanizzi</surname><given-names>P</given-names></name> <name><surname>Rizzi</surname><given-names>D</given-names></name> <name><surname>Signorile</surname><given-names>N</given-names></name> <name><surname>Cuscianna</surname><given-names>E</given-names></name> <name><surname>Daleno</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Burden of COVID-19 disease and vaccine coverages in Apulian splenectomized patients: a retrospective observational study</article-title>. <source>Br J Haematol</source>. (<year>2023</year>) <volume>201</volume>:<fpage>1072</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bjh.18731</pub-id>, <pub-id pub-id-type="pmid">36942786</pub-id></mixed-citation></ref>
<ref id="ref59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comparcini</surname><given-names>D</given-names></name> <name><surname>Cicolini</surname><given-names>G</given-names></name> <name><surname>Totaro</surname><given-names>M</given-names></name> <name><surname>Governatori</surname><given-names>L</given-names></name> <name><surname>Pastore</surname><given-names>F</given-names></name> <name><surname>Miniscalco</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>Influenza vaccination hesitancy and related factors among pregnant and breastfeeding women: a cross-sectional study</article-title>. <source>Hum Vaccin Immunother</source>. (<year>2025</year>) <volume>21</volume>:<fpage>2450858</fpage>. doi: <pub-id pub-id-type="doi">10.1080/21645515.2025.2450858</pub-id>, <pub-id pub-id-type="pmid">39809545</pub-id></mixed-citation></ref>
<ref id="ref60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resta</surname><given-names>E</given-names></name> <name><surname>Cuscianna</surname><given-names>E</given-names></name> <name><surname>Pierucci</surname><given-names>P</given-names></name> <name><surname>Custodero</surname><given-names>C</given-names></name> <name><surname>Solfrizzi</surname><given-names>V</given-names></name> <name><surname>Sabb&#x00E0;</surname><given-names>C</given-names></name> <etal/></person-group>. <article-title>Significant burden of post-COVID exertional dyspnoea in a South-Italy region: knowledge of risk factors might prevent further critical overload on the healthcare system</article-title>. <source>Front Public Health</source>. (<year>2023</year>) <volume>11</volume>:<fpage>1273853</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2023.1273853</pub-id>, <pub-id pub-id-type="pmid">38179561</pub-id></mixed-citation></ref>
<ref id="ref61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resta</surname><given-names>E</given-names></name> <name><surname>Quarato</surname><given-names>CMI</given-names></name> <name><surname>Scioscia</surname><given-names>G</given-names></name> <name><surname>Cuscianna</surname><given-names>E</given-names></name> <name><surname>Tondo</surname><given-names>P</given-names></name> <name><surname>Mansueto</surname><given-names>G</given-names></name> <etal/></person-group>. <article-title>Low-intensity rehabilitation in persistent post COVID-19 dyspnoea: the value of Spa health resort as appropriate setting</article-title>. <source>Ann Ig</source>. (<year>2024</year>) <volume>36</volume>:<fpage>597</fpage>&#x2013;<lpage>613</lpage>. doi: <pub-id pub-id-type="doi">10.7416/ai.2024.2617</pub-id>, <pub-id pub-id-type="pmid">38436080</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2950490/overview">Jill L. Tao</ext-link>, Incheon National University, Republic of Korea</p></fn>
<fn fn-type="custom" custom-type="reviewed-by" id="fn0002"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2159467/overview">Eustachio Cuscianna</ext-link>, University of Bari Aldo Moro, Italy</p><p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2242020/overview">Ricardo De Moraes E Soares</ext-link>, Naval School, Portugal</p></fn>
</fn-group>
</back>
</article>